Epsilon M&A Deal Report - Adare Pharmaceuticals (Adare Biome)
Transaction Multiples for the Valuation of Private Companies
Koninklijke DSM / Adare Pharmaceuticals (Adare Biome)
No EMAT :
112493
Announced Date :
19/04/2023
Type :
Acquisition of Majority Stake
Deal Value :
Yes
Acquirer :
Koninklijke DSM
Target :
Adare Pharmaceuticals (Adare Biome)
Country :
Yvelines
Sector of activity :
- Pharmaceuticals & Cosmetics > Health, Pharmaceuticals & Biotechnology > Pharmaceuticals
Business Description :
Adare Pharmaceuticals SAS (Adare Biome) develops, produces, and commercializes postbiotic solutions , including its pharmaceutical product Lactéol™ marketed in almost 40 countries around the world,...
Transaction multiples available
| EV/ Sales |
EV/ Gross Profit |
EV/ EBITDA |
EV/ EBIT |
Eq/ PBT |
P/E | Price to Book |
Specific multiple(s) |
|
|---|---|---|---|---|---|---|---|---|
| Historic | ns | |||||||
| Current | 
|
Rating :
***
|
|
Multiple available |
| n.s. | Multiple calculated, but not significant |
Source: Epsilon Research / EMAT
Comparable Transactions
- Number of EMAT Reports / sub-sector « Pharmaceuticals » = 129
| Date | Acquirer | Target | Country | Multiples | See details |
| 28/09/2020 | Series A fund raising by Greycroft and Bullpen Capital | Sempiternal Aesthetics (SISU Aesthetic Clinic) | Ireland | * | 112405 |
| 27/06/2019 | Dermedis | Clinique Matignon Suisse | Switzerland | * | 112356 |
Source: Epsilon Research / EMAT
